Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
- Weitere Titel
-
Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Zielgerichtete Kombinationstherapie: Entdeckung und Evaluierung synergistischer anti-Krebseffekte von anti-HER2-Duocarmycin Antikörper-Wirkstoff Konjugaten und ATR Inhibitoren
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2018
- Schlagwort
-
Therapeutics
Antibody-drug conjugates
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek Darmstadt
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:tuda-tuprints-86150
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rieker, Marcel
- Kolmar, Harald
- Hausch, Felix
- Universitäts- und Landesbibliothek Darmstadt
Entstanden
- 2020
Ähnliche Objekte (12)
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Targeted protein degradation of FK506-binding proteins
Synthesis and investigation of 2-substituted hetero-/arylacetic acids as bottom groups for selective inhibitors of the FK506-binding protein 51 (FKBP51)
In-cell analysis of FK506 binding protein 51-glucocorticoid receptor-heat shock protein 90 interaction at single residue resolution
Proximity-based screening of a class A/B hybrid G protein-coupled receptor
Modulation of the FKBP51 structure by protein engineering and isolation of conformation-locking antibodies and affibodies
Multifunktionale Nukleinsäure-Konjugate zur Selektion von katalytischen Oligonukleotiden
Multifunktionale Nukleinsäure-Konjugate zur Selektion von katalytischen Oligonukleotiden
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Binding pocket stabilization by high-throughput screening of yeast display libraries
Dextramabs: A Novel Format of Antibody‐Drug Conjugates Featuring a Multivalent Polysaccharide Scaffold
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Targeted protein degradation of FK506-binding proteins
Synthesis and investigation of 2-substituted hetero-/arylacetic acids as bottom groups for selective inhibitors of the FK506-binding protein 51 (FKBP51)
In-cell analysis of FK506 binding protein 51-glucocorticoid receptor-heat shock protein 90 interaction at single residue resolution
Proximity-based screening of a class A/B hybrid G protein-coupled receptor
Modulation of the FKBP51 structure by protein engineering and isolation of conformation-locking antibodies and affibodies
Multifunktionale Nukleinsäure-Konjugate zur Selektion von katalytischen Oligonukleotiden
Multifunktionale Nukleinsäure-Konjugate zur Selektion von katalytischen Oligonukleotiden
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Binding pocket stabilization by high-throughput screening of yeast display libraries
Dextramabs: A Novel Format of Antibody‐Drug Conjugates Featuring a Multivalent Polysaccharide Scaffold
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Targeted protein degradation of FK506-binding proteins
Synthesis and investigation of 2-substituted hetero-/arylacetic acids as bottom groups for selective inhibitors of the FK506-binding protein 51 (FKBP51)
In-cell analysis of FK506 binding protein 51-glucocorticoid receptor-heat shock protein 90 interaction at single residue resolution
Proximity-based screening of a class A/B hybrid G protein-coupled receptor
Modulation of the FKBP51 structure by protein engineering and isolation of conformation-locking antibodies and affibodies
Multifunktionale Nukleinsäure-Konjugate zur Selektion von katalytischen Oligonukleotiden
Multifunktionale Nukleinsäure-Konjugate zur Selektion von katalytischen Oligonukleotiden
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Binding pocket stabilization by high-throughput screening of yeast display libraries